腫瘤科5 篇

影響力 2

Baseline FDG PET/CT-Defined Axillary Burden Predicts Axillary Pathologic Complete Response After Neoadjuvant Therapy in Breast Cancer.

發表日期: 2026-06-01

Nuklearmedizin. Nuclear medicine

MediLens 收錄日: 2026-05-23

This study investigates predictors of axillary pathologic complete response (pCR) after neoadjuvant systemic therapy in clinically node-positive breast cancer. In a retrospective cohort of 115 patients, the rate of axillary pCR was 51.3%. The models developed showed good discrimination with AUC v...

在PubMed上閱讀

影響力 3

Fulvestrant versus capecitabine as maintenance therapy in hormone receptor-positive, HER2-negative metastatic breast cancer after first-line chemotherapy (FAMILY): a multicenter, open-label, randomized, phase 3 trial.

發表日期: 2026-05-22

Signal transduction and targeted therapy

MediLens 收錄日: 2026-05-23

This study evaluates the efficacy and safety of fulvestrant versus capecitabine as maintenance therapy in hormone receptor-positive, HER-2 negative metastatic breast cancer patients after first-line chemotherapy. The trial involved 210 patients and found that fulvestrant significantly improved me...

在PubMed上閱讀

影響力 3

Aptamer Nanoswitch-Mediated Lock-Expose Mechanism Enables Highly Sensitive In Vitro Detection and Precise In Situ Membrane Imaging of HER2 Protein.

發表日期: 2026-05-22

ACS sensors

MediLens 收錄日: 2026-05-23

This study presents a novel HER2-specific aptamer nanoswitch for the sensitive detection of HER2 expression in breast cancer. The sensor demonstrated a linear detection range from 10 fg/mL to 10 ng/mL and a limit of detection of 1.42 fg/mL. It successfully distinguished between healthy individual...

在PubMed上閱讀

影響力 3

Wash-Free Digital Detection of Tumor Extracellular Vesicles via Plasmonic Droplet Microfluidics.

發表日期: 2026-05-22

ACS sensors

MediLens 收錄日: 2026-05-23

PlasDroplex is a novel wash-free digital plasmonic assay designed for the early detection of tumor-derived extracellular vesicles (EVs) in cancer diagnostics. This method allows for the detection of EVs without the need for washing or multistep labeling, utilizing a coencapsulation of plasma with...

在PubMed上閱讀

影響力 3

Urine-Based Noninvasive Detection of Prostate Cancer Using Human Olfactory Receptor-Embedded Nanodiscs.

發表日期: 2026-05-22

ACS sensors

MediLens 收錄日: 2026-05-23

This study presents a novel urine-based diagnostic platform for prostate cancer that utilizes a sensor array embedded with human olfactory receptors, combined with fluorescence sensing and machine learning. The platform aims to improve specificity in diagnosing prostate cancer, addressing the lim...

在PubMed上閱讀

醫學研究趨勢

腫瘤科5 篇

Baseline FDG PET/CT-Defined Axillary Burden Predicts Axillary Pathologic Complete Response After Neoadjuvant Therapy in Breast Cancer.

Fulvestrant versus capecitabine as maintenance therapy in hormone receptor-positive, HER2-negative metastatic breast cancer after first-line chemotherapy (FAMILY): a multicenter, open-label, randomized, phase 3 trial.

Aptamer Nanoswitch-Mediated Lock-Expose Mechanism Enables Highly Sensitive In Vitro Detection and Precise In Situ Membrane Imaging of HER2 Protein.

Wash-Free Digital Detection of Tumor Extracellular Vesicles via Plasmonic Droplet Microfluidics.

Urine-Based Noninvasive Detection of Prostate Cancer Using Human Olfactory Receptor-Embedded Nanodiscs.

獲取個人化每日摘要